Home Press Releases Market for Deep Brain Stimulation Devices for Parkinson’s Disease to be Worth USD 9.4 Billion by 2019: Transparency Market Research
Market for Deep Brain Stimulation Devices for Parkinson’s Disease to be Worth USD 9.4 Billion by 2019: Transparency Market Research
Posted on Apr 16, 2014
According to a latest market research report published by Transparency Market Research, the global market for Deep Brain Stimulation Devices for Parkinson’s Disease is projected to be worth USD 9.4 billion by the end of 2019. The next few years are poised to be one of the most promising growth phases for this market considering it was valued at USD 4.5 billion as of 2012.
The insightful market research report is based on high-quality primary and secondary research with data collated via in-depth interviews and discussions with opinion leaders, besides an extensive study of market players’ product and corporate literature, annual reports and more.
The latest market research report titled “Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," projects that this market will report a compounded annual growth rate (CAGR) of 11% between 2013 and 2019.
The report provides users with an overview of the causative factors that will directly influence the demand for deep brain stimulation devices for treating persons suffering from Parkinson’s disease. It speaks about various neurological disorders such as Alzheimer’s disease, trauma, Parkinsonism, ischemic stroke and other similar disorders that are likely have a direct impact on the need for DBS devices.
Parkinson’s disease is characterized by symptoms such as postural instability, akinesia, and bradykinesia among others. In the recent past, incidences of Parkinson’s disease have increased multifold, making it the second-most common progressive and chronic neurodegenerative disorder.
The report suggests that some of the key factors that have caused an increase in the demand for DBS devices are a preference for surgical techniques that are minimally invasive-especially among the geriatric population that is more prone to this disorder. In fact, there is a growing inclination among medical practitioners as well as patients to choose DBS over drug therapy since drug therapy is known to have several side effects and its efficacy cannot be accurately gauged. The Parkinson’s Disease Foundation (PDF) estimates that nearly 10 million people worldwide suffer from this disorder, with one million of these living in America alone.
DBS surgical therapy is the therapy of choice in the advanced stages of Parkinson’s disease, whereas medical practitioners typically recommend chemotherapy in the early stages. The report discusses the aspects and considerations that make DBS devices a preferred option as compared to other treatment methods such as stem cell therapy, drug therapy, and physical therapy.
This market research report by Transparency Market Research also goes on to discuss the geographical segmentation of the deep brain stimulation devices market. The market is broadly segmented as North America, Asia-Pacific, Europe and Latin America. Users can expect to gain deep insights into the market potential and growth projections for each of these markets. It also talks about factors that will promote or restrain growth in these markets.
Furthermore, the market research report offers a detailed look at the leading companies operating in the market and their profiles.
To browse through the Deep Brain Stimulation Devices Market Report ToC or to purchase the report, please visit:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Ms. Sheela AK
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
Share This Article!
- Genetic Testing Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
- Genetic testing is oftenly performed as a part of genetic consultation. These tests are performed either on blood, skin, hair, or amniotic fluid. Genetic tests include the analysis of an individual’s genetic material (DNA or RNA), in order to determine the susceptibility to certain abnormalities or specific disorders or to identify the genetic differences (variants) if any. Currently, genetic tests have...
- Bioactive Wound Care Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020Advanced wound dressing materials made from biomaterials play an important role in the wound healing process are known as bioactive wound care dressings. Bioactive wound care dressings also comprise tissue-engineered products derived from artificial sources or natural tissues. These are usually formed by combining various polymers such as collagen, hyaluronic acid, elastin, alginates and chitosan. Wound...
- In-Vitro Colorectal Cancer Screening Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020Colorectal cancer also known as bowel cancer, rectal cancer, colorectal adenocarcinoma and colon cancer, is a type of cancer that results from uncontrolled growth of cells of rectum or colon (part of large intestine). Sometimes, cellular over-growth of appendix is also termed as colorectal cancer. Changes in bowel habit, rectal bleeding, anemia and weight loss are some of the common symptoms that a patient...